Literature DB >> 7521321

CFTR mutations in Chilean cystic fibrosis patients.

J Rios1, O Orellana, M Aspillaga, I Avendano, I Largo, N Riveros.   

Abstract

An analysis of five of the most common cystic fibrosis (CF) mutations worldwide (delta F-508, R-553X, G-551D, N-1303K and G-542X) was performed in 36 Chilean patients. Polymerase chain reaction (PCR) amplification of the DNA followed by allele specific restriction enzyme analysis was used for detection. The overall frequencies of the mutations in the chromosomes analyzed were 29.2% for delta F-508 and 4.2% for R-553X (n = 72). The G-542X, G-551D and N-1303 K mutations were absent in the Chilean sample. Our data suggest however that delta F-508 is not the most common CF mutation in Chilean patients. delta F-508 and R-553X account for only 33.4% of the alleles; 66.6% of them do not respond to the probes used and still remain uncharacterized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521321     DOI: 10.1007/bf00208286

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

Authors: 
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

2.  A fast method for high-quality genomic DNA extraction from whole human blood.

Authors:  S Gustincich; G Manfioletti; G Del Sal; C Schneider; P Carninci
Journal:  Biotechniques       Date:  1991-09       Impact factor: 1.993

3.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

4.  Rapid nonradioactive detection of the major cystic fibrosis mutation.

Authors:  J Rommens; B S Kerem; W Greer; P Chang; L C Tsui; P Ray
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

5.  Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.

Authors:  A Hamosh; B C Trapnell; P L Zeitlin; C Montrose-Rafizadeh; B J Rosenstein; R G Crystal; G R Cutting
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Delta F508 gene deletion in cystic fibrosis in southern Europe.

Authors:  X Estivill; M Chillon; T Casals; A Bosch; N Morral; V Nunes; P Gasparini; A Seia; P F Pignatti; G Novelli
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

7.  [Genetic characterization of the hospital population of Santiago, Chile].

Authors:  L Cifuentes; C Y Valenzuela; R Cruz-Coke; L Armanet; C Lyng; Z Harb
Journal:  Rev Med Chil       Date:  1988-01       Impact factor: 0.553

8.  A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein.

Authors:  G R Cutting; L M Kasch; B J Rosenstein; J Zielenski; L C Tsui; S E Antonarakis; H H Kazazian
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

Review 9.  Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis.

Authors:  I McIntosh; G R Cutting
Journal:  FASEB J       Date:  1992-07       Impact factor: 5.191

Review 10.  The spectrum of cystic fibrosis mutations.

Authors:  L C Tsui
Journal:  Trends Genet       Date:  1992-11       Impact factor: 11.639

View more
  1 in total

1.  Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity.

Authors:  L R Desviat; B Pérez; M De Lucca; V Cornejo; B Schmidt; M Ugarte
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.